Disposition of the New Potent Acetylcholinesterase Inhibitor 8-[3-[1-[(3-fluorophenyl)methyl]-4-piperidiny]-1-oxopropyl]-1,
2, 5, 6-tetrahydro-4H-pyrrolo [3, 2, 1-ij] quinolin-4-one (TAK-802) in Rats, Dogs and Monkeys
Authors
M. Kakehi
1
Drug Metabolism and Pharmacokinetics Research Laboratory, Pharmaceutical Research
Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Y. Tagawa
1
Drug Metabolism and Pharmacokinetics Research Laboratory, Pharmaceutical Research
Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan
T. Kondo
1
Drug Metabolism and Pharmacokinetics Research Laboratory, Pharmaceutical Research
Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan
S. Asahi
1
Drug Metabolism and Pharmacokinetics Research Laboratory, Pharmaceutical Research
Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan